Decision-making under uncertainty in drug development - IMT Mines Albi-Carmaux Accéder directement au contenu
Communication Dans Un Congrès Année : 2010

Decision-making under uncertainty in drug development

Résumé

In pharmaceutical industry, decision-makers have to decide whether to continue drug development projects which are very expensive, risky and long. Such decisions are made collectively, under a high degree of uncertainty and in non-emergency situations. The major problem in this context is indecision. In order to improve the decision-making process in practice, we need to characterize and analyze situations of decision-making under uncertainty. In this paper, we propose a new definition of uncertainty that takes human factors in its characterization into account. Then, we present a typology of uncertainty generators that helps us recognize and explore its causal factors. Additionally, we represent decision-making process in pharmaceutical R\&D illustrating the role of different actors and their interactions in decision-making. This should help decision-makers adopt proactive practices instead of reactive ones.
Fichier principal
Vignette du fichier
IPMA_FullPaper_Farnoud.pdf (495.58 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00745303 , version 1 (25-10-2012)

Identifiants

  • HAL Id : hal-00745303 , version 1

Citer

Saïna Hassanzadeh, Didier Gourc, François Marmier, Sophie Bougaret. Decision-making under uncertainty in drug development. 24th World Congress International Project Management Association, Nov 2010, Istanbul, Turkey, France. pp.1. ⟨hal-00745303⟩
195 Consultations
1561 Téléchargements

Partager

Gmail Facebook X LinkedIn More